EUVIMEDEUVIMED entdecken
Crossref

Synergistic pharmacotherapy for epilepsy: NPY (3–36)-modified ZIF-90 nanoparticles co-delivering GW2580

Peipei Cao, Chao Geng, Xinghui Ren, Xiaoqi Chu, Yiting Zhai, Wenyou Li, Changxin Wu

Biomaterials Science · 2026

DOI: 10.1039/d5bm01868d ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2026. Verfasst von Peipei Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical and Health Laboratory in Shanxi Province, Key Laboratory of Chemical Biology and Molecular Engineering of the Ministry of Education, and I…. Hauptthemen laut MEDLINE: Epilepsy, Anticonvulsants, Neuropeptide Y, Nanoparticles. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Fundamental Research Program of Shanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mechanisms underlying NPY@ZIF-RG synergistic pharmacotherapy for epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyAnticonvulsantsNeuropeptide YNanoparticlesImidazolesAnimalsMiceBlood-Brain BarrierMaleKainic AcidHumansDrug SynergismMetal-Organic Frameworks

Substanzen

AnticonvulsantsNeuropeptide YImidazolesKainic AcidZIF-90Metal-Organic Frameworks

Autor:innen und Institutionen

  • Biomedical and Health Laboratory in Shanxi Province, Key Laboratory of Chemical Biology and Molecular Engineering of the Ministry of Education, and Institutes of Biomedical Sciences, Shanxi University, Taiyuan 237016, C…
  • Department of Medical Genetics, Capital Center for Children's Health, Capital Medical University, Beijing 100020, China.
  • College of Chemistry and Materials Science, Hebei University, Baoding, Hebei 071000, China.
  • Department of Neurology, Beijing Haidian Hospital, Beijing 100000, China.
  • State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Center for Analytical Sciences, College of Chemistry, Nankai University, Tianjin 300071, China…

Förderung

  • Fundamental Research Program of Shanxi Province

Zitieren

APA

Cao, P., Geng, C., Ren, X., Chu, X., Zhai, Y., Li, W., & Wu, C. (2026). Synergistic pharmacotherapy for epilepsy: NPY (3–36)-modified ZIF-90 nanoparticles co-delivering GW2580. Biomaterials Science. https://doi.org/10.1039/d5bm01868d

Vancouver

Cao P, Geng C, Ren X, Chu X, Zhai Y, Li W, et al. Synergistic pharmacotherapy for epilepsy: NPY (3–36)-modified ZIF-90 nanoparticles co-delivering GW2580. Biomaterials Science. 2026. doi:10.1039/d5bm01868d

BibTeX
@article{Cao2026,
  author = {Cao, Peipei and Geng, Chao and Ren, Xinghui and Chu, Xiaoqi and Zhai, Yiting and Li, Wenyou and Wu, Changxin},
  title = {Synergistic pharmacotherapy for epilepsy: NPY (3–36)-modified ZIF-90 nanoparticles co-delivering GW2580},
  journal = {Biomaterials Science},
  year = {2026},
  doi = {10.1039/d5bm01868d}
}
Kostenlos starten →